Cargando…
Remdesivir: Quo vadis?()
Remdesivir (GS-5734, Veklury®) has remained the only antiviral drug formally approved by the US FDA for the treatment of Covid-19 (SARS-CoV-2 infection). Its key structural features are the fact that it is a C-nucleoside (adenosine) analogue, contains a 1′-cyano function, and could be considered as...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8524699/ https://www.ncbi.nlm.nih.gov/pubmed/34678228 http://dx.doi.org/10.1016/j.bcp.2021.114800 |